Magnify: A Phase IIIB Trial Shows Promising Efficacy in the Treatment of Relapsed/Refractory, Indolent Non-Hodgkin Lymphoma Patients with Lenalidomide in Combination with Rituximab (R-2)-MedSci.cn

Magnify: A Phase IIIB Trial Shows Promising Efficacy in the Treatment of Relapsed/Refractory, Indolent Non-Hodgkin Lymphoma Patients with Lenalidomide in Combination with Rituximab (R-2)

Rummer, M; Andorsky, DJ; Schmidt, B; La Rosee, P; Graeven, I; Czuczman, M; Llorente, M; Li, JH; Sharman, J

ONCOLOGY RESEARCH AND TREATMENT, 2020; 43 (): 238

科室
- - 订阅+
  - 更多科室
工具
服务